Skip to main content

Laboratory of Experimental Medicine

The Laboratory of Experimental Medicine (LEM) was established in 1998 at the Department of Pediatrics, Faculty of Medicine and Dentistry, Palacky University and University Hospital in Olomouc. Later in 2010, the LEM became a moving force in building-up and establishment of the Institute of Molecular and Translational Medicine. 

Our researchers are organized to research groups and perform molecular, cellular and integrative research at the highest international level and to train a new generation of successful scientists. We study biological processes that govern normal and pathological human bodily functions that are involved in disease pathogenesis. Albeit our research is disease agnostic, most of our expertise relates to cancer, inflammation, infection, rare diseases and neurodegeneration. Our spectrum of research ranges from basic and translational science, including research and development of small molecules, radiopharmaceutics, identification of new therapeutic targets, drug repurposing, first use of molecules in man (Phase I trials), biomarker identification and validation trials, development of in vitro diagnostics, through to real-world evidence studies using routinely collected data.Several of our research environments have been recognized as outstanding both at the national and European levels. We also strive to stimulate our young researchers with our enthusiasm for research and wish to increase their interest in both basic and applied sciences. We expose them to the most up-to-date science, cutting edge technologies and prepare them for lifelong learning in their future careers. 

Research interests
Our research interests and domains include
  • Research and development of small molecules and biologics for innovative therapies
  • Imaging and tracing of human diseases, development of radiopharmaceutics
  • Identification and validation diagnostic, prognostic and predictive biomarkers to advance early disease diagnostics and personalized medicine
  • Better understanding disease complexity employing multidimensional -omic techniques (proteomics, genomics, transcriptomics, metabolomics, lipidomics, cellulomics, etc.)
  • Advancing high-throughput biology and screening techniques in medical research
  • Research on translational in vitro and in vivo models (e.g. organoids, patient-derived xenografts, induced pluripotent stem cells)
  • Development of information technologies, including the artificial intelligence, and solutions to support data stewardship in biomedical domain
  • Advancing nanotechnologies for treatment and detection of human disorders; Proof-of-concept preclinical and early clinical trials.